NCT03973762View on ClinicalTrials.gov

A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography

NACompletedINTERVENTIONAL
Enrollment

1,081

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

July 15, 2020

Study Completion Date

August 15, 2020

Conditions
Diabetic Retinopathy
Interventions
DEVICE

DR Grading with CAD

A CAD system is used to make DR grading.

OTHER

DR Grading by expert panel

DR Grading by expert panel

Trial Locations (1)

100005

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

collaborator

Beijing Tongren Hospital

OTHER

collaborator

Chinese PLA General Hospital

OTHER

lead

Peking Union Medical College Hospital

OTHER

NCT03973762 - A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography | Biotech Hunter | Biotech Hunter